Reaction

Red Blood Cell Sedimentation Rate Abnormal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,297 reports · 95 co-occurring drugs

As of the last recalculation, Red Blood Cell Sedimentation Rate Abnormal appears in 2,297 FAERS reports alongside 95 co-occurring drug terms. The strongest observed disproportionality signal is ABATACEPT (PRR 282.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Abatacept	1,502	282.1	285.2
Anakinra	421	281.3	288.7
Tocilizumab	1,380	273.0	276.4
Leflunomide	1,321	267.9	271.3
Hydroxychloroquine Sulfate	1,197	247.5	250.8
Naproxen Sodium Tablet, Coated	309	238.8	244.3
Naproxen Sodium, Coated Tablets	309	238.8	244.3
Naproxen Sodium 220Mg	309	238.4	244.0
Sulfasalazine	1,073	232.3	235.6
Hydroxychloroquine	994	211.9	214.8
Desoximetasone	360	202.8	206.8
Methotrexate Sodium	1,797	150.3	150.9
Methotrexate	1,653	124.4	124.9
Etanercept	1,747	107.3	107.6
Cortisone Acetate	122	94.5	95.4
Tofacitinib	1,051	94.3	94.9
Risedronate Sodium	256	83.9	84.6
Adalimumab-Fkjp	352	81.1	81.8
Adalimumab-Aaty	352	79.4	80.0
Adalimumab-Adaz	363	73.8	74.4
Naproxen	491	71.8	72.2
Infliximab	952	66.8	67.1
Golimumab	481	64.0	64.4
Tofacitinib Citrate	85	61.0	61.4
Triamcinolone Acetonide Ointment Usp, 0.05%	142	58.5	58.9
Calcium Gluconate	70	54.3	54.6
Naproxen Sodium	597	50.8	51.0
Adalimumab	1,441	47.8	47.9
Rosuvastatin Calcium	137	46.8	47.0
Human Immunoglobulin G	100	45.9	46.1
Triamcinolone Acetonide	142	44.3	44.5
Folic Acid	751	40.1	40.2
Pseudoephedrine Hydrochloride	40	35.9	36.0
Methylprednisolone Acetate	31	35.5	35.7
Cetirizine Hydrochloride Allergy	112	35.2	35.3
Cetirizine Hydrochloride Tablets	112	35.2	35.3
Rituximab	605	34.8	34.9
Pseudoephedrine Hcl	40	33.5	33.6
Certolizumab Pegol	362	33.0	33.1
Prednisone	1,022	32.4	32.4
Celecoxib	379	31.0	31.1
Pantoprazole Sodium In 0.9% Sodium Chloride	189	30.0	30.1
Pantoprazole Sodium Injection	189	30.0	30.1
Diclofenac Sodium 1%	105	27.9	27.9
Diclofenac Sodium Topical	105	27.9	27.9
Diclofenac Sodium Topical Gel, 1%	105	27.8	27.9
Azathioprine	230	26.2	26.2
Minocycline	33	26.0	26.1
Ascorbic Acid	54	21.5	21.6
Canakinumab	25	21.2	21.2
Cyclobenzaprine Hydrochloride	20	20.3	20.4
Moxifloxacin Hydrochloride	40	18.2	18.2
Cetirizine	132	16.3	16.3
Quetiapine Fumarate	43	13.4	13.5
Alendronate Sodium	139	13.2	13.2
Pantoprazole Sodium	192	12.7	12.7
Diclofenac	115	12.7	12.7
Ramipril	161	12.6	12.6
Bupropion Hydrochloride	128	12.4	12.4
Tobramycin Solution	16	12.1	12.2
Pantoprazole	293	11.9	11.9
Doxyclycline Hyclate	22	11.8	11.8
Tobramycin Sulfate	16	11.8	11.8
Diclofenac Potassium, Film Coated	10	10.8	10.8
Diclofenac Potassium Tablets	10	10.8	10.8
Naproxen Sodium Tablet	61	10.7	10.7
Secukinumab	175	10.6	10.6
Acetaminophen And Codeine	14	10.5	10.5
Canagliflozin	33	10.1	10.1
Cetiirizine	46	10.0	10.0
Leucovorin Calcium	20	9.6	9.6
Metronidazole Topical	48	9.3	9.3
Chlorhexidine Gluconate	9	9.0	9.0
Diclofenac Potassium	10	8.4	8.4
Metformin Hydrochloride Tablets	52	8.4	8.4
Metformin Hydrochloride Extended-Release Tablets	52	8.4	8.4
Metformin Hydrochloride Tablet	52	8.4	8.4
Atenolol	116	8.3	8.3
Indapamide	16	8.1	8.1
Metformin Hydrochloride	52	8.1	8.1
Cetirizine Hydrochloride	132	7.6	7.6
Mycophenolate Mofetil	109	7.6	7.6
Mycophenolate Mofetil Hydrochloride	109	7.6	7.6
Diclofenac Sodium	115	7.2	7.2
Vitamin C	68	6.9	6.9
Cyclosporine	79	6.6	6.6
Ustekinumab	70	6.4	6.4
Tobramycin	16	6.1	6.1
Botulinum Toxin Type A	8	5.9	5.9
Metformin Er 500 Mg	172	5.5	5.5
Metformin Er 750 Mg	172	5.5	5.5
Apremilast	86	5.5	5.5
Conjugated Estrogens	31	4.9	4.9
Estrogens, Conjugated	31	4.8	4.8
Sarilumab	13	4.5	4.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.